Home > Back to Publisher > Report Information

Nucleic Acid Purification Life Science Dashboard™ Series 3

Percepta Associates, Inc.
September 11, 2011
255 Pages - SKU: PCT6639928

Abstract Table of Contents Search inside this report Related Reports

Nucleic acid purification is one of the few basic methods ubiquitous among scientists using molecular biology techniques to investigate processes such as gene expression, genetic diversity, protein function and molecular interactions. The Nucleic Acid Purification Dashboard was developed from responses to a 20-question survey of 506 scientists predominantly located in North America and Europe.

This Dashboard reveals key market indicators for the nucleic acid purification market as a whole as well as for the following sub-segments:

Gel extraction
Post-reaction cleanup (i.e. PCR, enzyme digestion)
Plasmid DNA minipreps (1-2 ml culture)
Plasmid DNA midipreps (5-50 ml culture)
Plasmid DNA maxipreps (100 ml culture or more)
Genomic DNA from cells or tissue
Genomic DNA from whole blood
Genomic DNA from FFPE tissue
Total RNA from cells or tissue
Total RNA from whole blood
Total RNA from FFPE tissue
mRNA
microRNA

Please note, the online download version is a global site license version of the report.

Executive Summary: Key Findings and Implications; Nucleic Acid Purification Dashboard; Nucleic Acid Purification Market Opportunity Matrix; Survey Methodology; Survey Invitation Text; Respondent Demographics; Frequency of Performance of Life Science Techniques; Frequency of Nucleic Acid Purification Product Use; Frequency of Co-Performance of Techniques and Methods; Throughput/Usage Rates and Market Growth Rates; Stated Price for Nucleic Acid Purification Products; Market Segment Sizes, Total Market Size and Total Market Growth Rate; Market Shares by Segment (Share of Mention); Customer Satisfaction And Interest In Switching Suppliers; Product Features That Influence Purchasing Decisions; Primary and Secondary Downstream Applications; Desired Changes to Nucleic Acid Purification Products
Survey Questionnaire
Appendix
List of Figures: Figure 1: Respondents' Place of Employment; Figure 2: Respondents' Country/Region; Figure 3: Respondents' Job Title; Figure 4: Respondents' Areas of Expertise/Specialization; Figure 5: Number of Employees in Respondents' Laboratories; Figure 6: Respondents’ Primary and Secondary Species Focus; Figure 7: Percentage of Respondents Performing Various Life Science Techniques at Least a Few Times per Year; Figure 8: Percentage of Respondents Performing Nucleic Acid Purification; Figure 8A: Change in Percentage of Respondents Performing Nucleic Acid Purification; Figure 9: Percentage of Respondents Using Various Types of Nucleic Acid Purification Products in Their Laboratories; Figure 10: Percentage of Respondents Performing Gel Extraction; Figure 11: Percentage of Respondents Performing Post-reaction Cleanup; Figure 12: Percentage of Respondents Performing Plasmid DNA Miniprep Purification; Figure 12A: Change in Percentage of Respondents Performing Plasmid DNA Miniprep Purification; Figure 13: Percentage of Respondents Performing Plasmid DNA Midiprep Purification; Figure 13A: Change in Percentage of Respondents Performing Plasmid DNA Midiprep Purification; Figure 14: Percentage of Respondents Performing Plasmid DNA Maxiprep Purification; Figure 14A: Change in Percentage of Respondents Performing Plasmid DNA Maxiprep Purification; Figure 15: Percentage of Respondents Performing Genomic DNA Purification from Cells or Tissue; Figure 15A: Change in Percentage of Respondents Performing Genomic DNA Purification from Cells or Tissue; Figure 16: Percentage of Respondents Performing Genomic DNA Purification from Whole Blood; Figure 16A: Change in Percentage of Respondents Performing Genomic DNA Purification from Whole Blood; Figure 17: Percentage of Respondents Performing Genomic DNA Purification from FFPE Tissue; Figure 18: Percentage of Respondents Performing Total RNA Purification from Cells or Tissue; Figure 18A: Change in Percentage of Respondents Performing Total RNA Purification from Cells or Tissue; Figure 19: Percentage of Respondents Performing Total RNA Purification from Whole Blood; Figure 19A: Change in Percentage of Respondents Performing Total RNA Purification from Whole Blood; Figure 20: Percentage of Respondents Performing Total RNA Purification from FFPE Tissue; Figure 21: Percentage of Respondents Performing mRNA Purification; Figure 21A: Change in Percentage of Respondents Performing mRNA Purification; Figure 22: Percentage of Respondents Performing microRNA Purification; Figure 22A: Change in Percentage of Respondents Performing microRNA Purification; Figure 23: Respondents' Primary Supplier for Gel Extraction Products; Figure 24: Respondents' Primary Supplier for Post-reaction Cleanup Products; Figure 25: Respondents' Primary Supplier for Plasmid DNA Miniprep Purification Products; Figure 25A: Change in Mention of Primary Supplier for Plasmid DNA Miniprep Purification Products; Figure 26: Respondents' Primary Supplier for Plasmid DNA Midiprep Purification Products; Figure 26A: Change in Mention of Primary Supplier for Plasmid DNA Midiprep Purification Products; Figure 27: Respondents' Primary Supplier for Plasmid DNA Maxiprep Purification Products; Figure 27A: Change in Mention of Primary Supplier for Plasmid DNA Maxiprep Purification Products; Figure 28: Respondents' Primary Supplier for Purifying Genomic DNA from Cells or Tissue; Figure 28A: Change in Mention of Primary Supplier for Purifying Genomic DNA from Cells or Tissue; Figure 29: Respondents' Primary Supplier for Purifying Genomic DNA from Whole Blood; Figure 29A: Change in Mention of Primary Supplier for Purifying Genomic DNA from Whole Blood; Figure 30: Respondents' Primary Supplier for Purifying Genomic DNA from FFPE Tissue; Figure 31: Respondents' Primary Supplier for Purifying Total RNA from Cells or Tissue; Figure 31A: Change in Mention of Primary Supplier for Purifying Total RNA from Cells or Tissue; Figure 32: Respondents' Primary Supplier for Purifying Total RNA from Whole Blood; Figure 32A: Change in Mention of Primary Supplier for Purifying Total RNA from Whole Blood; Figure 33: Respondents' Primary Supplier for Purifying Total RNA from FFPE Tissue; Figure 34: Respondents' Primary Supplier for Purifying mRNA; Figure 34A: Change in Mention of Primary Supplier for Purifying mRNA; Figure 35: Respondents' Primary Supplier for Purifying microRNA; Figure 35A: Respondents' Primary Supplier for Purifying microRNA; Figure 36: Percentage of Respondents That Have Switched Suppliers in the Last Six Months; Figure 37: Most Important Features of Products for Nucleic Acid Purification; Figure 38: Respondents' Primary Application for Purified Gel Extraction Nucleic Acids; Figure 39: Respondents' Primary & Secondary Applications for Purified Gel Extraction Nucleic Acids; Figure 40: Respondents' Primary Application for Purified Post-reaction Cleanup Nucleic Acids; Figure 41: Respondents' Primary & Secondary Applications for Purified Post-reaction Cleanup Nucleic Acids; Figure 42: Respondents' Primary Application for Purified Plasmid Miniprep DNA; Figure 43: Respondents' Primary & Secondary Applications for Purified Plasmid Miniprep DNA; Figure 44: Respondents' Primary Application for Purified Plasmid Midiprep DNA; Figure 45: Respondents' Primary & Secondary Applications for Purified Plasmid Midiprep DNA; Figure 46: Respondents' Primary Application for Purified Plasmid Maxiprep DNA; Figure 47: Respondents' Primary & Secondary Applications for Purified Plasmid Maxiprep DNA; Figure 48: Respondents' Primary Application for Genomic DNA Purified from Cells or Tissue; Figure 49: Respondents' Primary & Secondary Applications for Genomic DNA Purified from Cells or Tissue; Figure 50: Respondents' Primary Application for Genomic DNA Purified from Whole Blood; Figure 51: Respondents' Primary & Secondary Applications for Genomic DNA Purified from Whole Blood; Figure 52: Respondents' Primary Application for Genomic DNA Purified from FFPE Tissue; Figure 53: Respondents' Primary & Secondary Applications for Genomic DNA Purified from FFPE Tissue; Figure 54: Respondents' Primary Application for Total RNA Purified from Cells or Tissue; Figure 55: Respondents' Primary & Secondary Applications for Total RNA Purified from Cells or Tissue; Figure 56: Respondents' Primary Application for Total RNA Purified from Whole Blood; Figure 57: Respondents' Primary & Secondary Applications for Total RNA Purified from Whole Blood; Figure 58: Respondents' Primary Application for Total RNA Purified from FFPE Tissue; Figure 59: Respondents' Primary & Secondary Applications for Total RNA Purified from FFPE Tissue; Figure 60: Respondents' Primary Application for Purified mRNA; Figure 61: Respondents' Primary & Secondary Applications for Purified mRNA; Figure 62: Respondents' Primary Application for Purified microRNA; Figure 63: Respondents' Primary & Secondary Applications for Purified microRNA; Figure 64: Non-current Users of Nucleic Acid Purification Products - Future Plans
List of tables: Table 1: Respondents' Areas of Expertise/Specialization (Values for Figure 4); Table 2: Frequency of Performance of Various Life Science Techniques; Table 3: Frequency of Co-Performance of Various Life Science Techniques; Table 4: Frequency of Use for Various Nucleic Acid Purification Products; Table 5: Frequency of Co-Performance of Life Science Techniques with Various Nucleic Acid Purification Methods; Table 6: Frequency of Co-Performance of Nucleic Acid Purification Methods with Various Life Science Techniques; Table 7: Co-Performance of Various Nucleic Acid Purification Methods; Table 8: Median and Average Monthly Throughput for Nucleic Acid Purification Methods; Table 8A: Change in Median Monthly Throughput for Nucleic Acid Purification Methods; Table 9: Percentage of Respondents Performing Various Numbers of Purification Reactions Per Month; Table 10: Projected Growth Rates for Various Nucleic Acid Purification Methods; Table 11: Median and Average Price Per Prep for Nucleic Acid Purification Products; Table 11A: Change in Median and Average Price Per Prep for Nucleic Acid Purification Products; Table 12: Estimated 2012 Global Market Size for Nucleic Acid Purification Products by Category; Table 13: Respondents’ Primary Supplier for Nucleic Acid Purification Products; Table 14: Respondents' Primary Supplier for Gel Extraction Products by Market Segment; Table 15: Respondents' Primary Supplier for Post-reaction Cleanup Products by Market Segment; Table 16: Market Share Leaders for Gel Extraction and Post-reaction Cleanup Products; Table 17: Respondents' Primary Supplier for Plasmid DNA Miniprep Purification Products by Market Segment; Table 18: Respondents' Primary Supplier for Plasmid DNA Midiprep Purification Products by Market Segment; Table 19: Respondents' Primary Supplier for Plasmid DNA Maxiprep Purification Products by Market Segment; Table 20: Market Share Leaders for Plasmid DNA Purification Products; Table 21: Respondents' Primary Supplier for Purifying Genomic DNA from Cells or Tissue by Market Segment; Table 22: Respondents' Primary Supplier for Purifying Genomic DNA from Whole Blood by Market Segment; Table 23: Respondents' Primary Supplier for Purifying Genomic DNA from FFPE Tissue Products by Market Segment; Table 24: Market Share Leaders for Genomic DNA Purification Products; Table 25: Respondents' Primary Supplier for Purifying Total RNA from Cells or Tissue by Market Segment; Table 26: Respondents' Primary Supplier for Purifying Total RNA from Whole Blood by Market Segment; Table 27: Respondents' Primary Supplier for Purifying Total RNA from FFPE Tissue by Market Segment; Table 28: Respondents' Primary Supplier for Purifying mRNA by Market Segment; Table 29: Respondents' Primary Supplier for Purifying microRNA by Market Segment; Table 30: Market Share Leaders for RNA Purification Products; Table 31: Percentage of Respondents Satisfied with Various Nucleic Acid Purification Product Categories and Reasons for Dissatisfaction; Table 32: Percentage of Respondents Satisfied with Nucleic Acid Purification Product Categories - Comparison to 2009 Nucleic Acid Purification Dashboard; Table 33: Most Important Features of Products for Nucleic Acid Purification - Comparison to 2009 Nucleic Acid Purification Dashboard

Nucleic Acid Purification Life Science Dashboard™ Series 3

Share this report

Other tasks

Research Assistance

Related Markets

Antisense & RNAi Technology Reports

Free Alert Me service